Olawole Olafisoye
Overview
Explore the profile of Olawole Olafisoye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Ghitan M, et al.
J Antimicrob Chemother
. 2016 Jun;
71(10):2945-8.
PMID: 27353464
Objectives: The study objective was to examine the epidemiological trends of KPC-producing Klebsiella pneumoniae in New York City medical centres. Patients And Methods: Single patient isolates of K. pneumoniae were...
2.
Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Quale J, et al.
Antimicrob Agents Chemother
. 2015 Jun;
59(8):4856-60.
PMID: 26033723
Multidrug-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae are endemic to hospitals in New York City and other regions. RPX7009 is a novel β-lactamase inhibitor with activity against serine carbapenemases. We tested...
3.
Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, et al.
Antimicrob Agents Chemother
. 2015 May;
59(8):5029-31.
PMID: 26014931
Imipenem with relebactam was active against Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp., including K. pneumoniae carbapenemase (KPC)-producing isolates. Loss of OmpK36 in KPC-producing K. pneumoniae isolates affected the susceptibility...
4.
Abdallah M, Olafisoye O, Cortes C, Urban C, Charles C, Landman D, et al.
Am J Infect Control
. 2015 Mar;
43(6):650-2.
PMID: 25818022
We compared susceptibilities of Acinetobacter baumannii and Pseudomonas aeruginosa collected during surveillance studies conducted during 2009 and 2013-2014 involving hospitals in New York City. There were significant decreases in the...
5.
Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J
Antimicrob Agents Chemother
. 2014 Dec;
59(3):1802-5.
PMID: 25534744
Eravacycline demonstrated in vitro activity against a contemporary collection of more than 4,000 Gram-negative pathogens from New York City hospitals, with MIC50/MIC90 values, respectively, for Escherichia coli of 0.12/0.5 μg/ml,...